Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: A comparative study using flexible and rigid applicators

Gynecologic Oncology

Volumn 91, Issue 2, 2003, Pages 285-292

  Datta, Niloy R ^a   Basu, Rimpa ^a   Das, Koilpillai J M ^a   Rajasekar, David ^a   Pandey, Chandra M ^a   Ayyagari, Sunder ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Applicator geometry; Brachytherapy; Cervix cancer; High dose rate; ICRU Report 38

Indexed keywords

ARTICLE; BLADDER; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COBALT TELETHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSIMETRY; FEMALE; GEOMETRY; HEIGHT; HUMAN; INTRACAVITARY BRACHYTHERAPY; LYMPH VESSEL; PELVIS; PRIORITY JOURNAL; RADIATION APPLICATOR; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECTUM; RIGIDITY; THICKNESS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA; UTERUS;

EID: 0242352460     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00506-7     Document Type: Article

References (23)

1. Orton C.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys. 21:1991;1425-1434.
2. Dose and volume specification for reporting intracavitary therapy in gynaecology. 1985;International Commission on Radiation Units and Measurements, Bethesda, MD.
3. Pötter R., Limbergen E.V., Gerstner N., Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. Radiother Oncol. 58:2001;11-18.
4. Bahena J.H., Martinez A., Yan D., et al. Spatial reproducibility of the ring and tandem high dose rate cervix applicator. Int J Radiat Oncol Biol Phys. 41:1998;13-19.
5. Datta N.R., Kumar S., Das K.J.M., Pandey C.M., Halder S., Ayyagari S. Variations of intracavitary applicator geometry during multiple HDR brachytherapy insertions in carcinoma cervix and its influence on reporting as per ICRU Report 38. Radiother Oncol. 60:2001;15-24.
6. Grigsby P.W., Georgiou A., Williamson J.W., Perez C.A. Anatomic variation of gynecologic brachytherapy prescription points. Int J Radiat Oncol Biol Phys. 27:1993;725-729.
7. Hoskin P.J., Cook M., Bouscale D., Cansdale B.J. Changes in applicator position with fractionated high dose rate gynaecological brachytherapy. Radiother Oncol. 40:1996;59-62.
8. Kim R.Y., Meyer J.T., Plott W.E., et al. Major geometric variations between multiple high-dose-rate applications of brachytherapy in cancer of the cervix frequency and types of variations. Radiology. 195:1995;419-422.
9. Kim R.Y., Meyer J.T., Spencer S.A., Meredith R.F., Jennelle R.L.S., Salter M.M. Major geometric variations between multiple intracavitary applications in carcinoma of the cervix high dose rate vs. low dose rate. Int J Radiat Oncol Biol Phys. 35:1996;1035-1038.
10. Pham H.T., Chen Y., Rouby E., Lustig R.A., Wallner P.E. Changes in high-dose-rate tandem and ovoid applicator positions during treatment in an unfixed brachytherapy system. Radiology. 206:1998;525-531.
11. Tod M.C., Meredith W.J. Treatment of cancer of the cervix uteri a revised "Manchester method" Br J Radiol. 26:1953;252-257.
12. Das K.R., Shanta A., Kulkarni R.N., Shah P.K. Ralstron 20B a high dose rate remote controlled afterloader for brachytherapy. Endocurie Hyperthermia Oncol. 3:1987;81-89.
13. Nag S., Erickson B., Thomadsen B., Orton C., Demanes J.D., Petereit D. The American Brachytherapy Society recommendations for high dose rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 48:2000;201-211.
14. Nag S., Orton C., Young D., Erickson B. The American Brachytherapy Society survey of brachytherapy practice for carcinoma of the cervix in the United States. Gynecol Oncol. 73:1999;111-118.
15. Jones D.A., Notley H.M., Hunter R.D. Geometry adopted by Manchester radium applicators and Selectron afterloading applicators in intracavitary treatment for carcinoma cervix uteri. Br J Radiol. 60:1987;481-485.
16. Elhanafy O.A., Das R.K., Paliwal B.R., Migahed M.D., Sakr H.A., Elleithy M. Anatomic variation of prescription points and treatment volume with fractionated high-dose-rate gynecological brachytherapy. J Appl Clin Med Phys. 2:2002;114-120.
17. King G.C., Bloomer W.D., Kalnicki S., et al. Point dose variations with time during traditional brachytherapy for cervical carcinoma. Med Dosim. 25:2000;77-80.
18. Visser A.G., Symonds R.P. Dose and volume specification for reporting gynaecological brachytherapy time for a change. Radiother Oncol. 58:2001;1-4.
19. Grigsby P.W., Willamson J.F., Chao K.S.C., Perez C.A. Cervical tumor control evaluated with ICRU 38 reference volumes and integrated reference air kerma. Radiother Oncol. 58:2001;19-23.
20. Prescribing, recording and reporting photon beam therapy. 1993;International Commission on Radiation Units and Measurements, Bethesda, MD.
21. Gebara W.J., Weeks K.J., Jones E.L., Montana G.S., Anscher M.S. Carcinoma of the uterine cervix a 3D-CT analysis of dose to the internal, external and common iliac nodes in tandem and ovoid applications. Radiother Oncol. 56:2000;43-48.
22. Schoeppel S.L., Ellis J.H., LaVigne M.L., Schea R.A., Roberts J.A. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys. 23:1992;169-174.
23. Miller T.R., Grigsby P.W. Measurements of tumour volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 53:2002;353-359.